Viewing nowLipyone Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

MFDS item code 200703129 · Notified 2007.03.13 · Insurance code 671800570
Improvement of hyperlipidemia; prevention of cardiovascular diseases (including myocardial infarction and stroke)
This drug is used to reduce the risk of cardiovascular diseases. It helps in reducing the risk of myocardial infarction, stroke, vascular procedures, and angina in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. It can also reduce the risk of hospitalizations and the occurrence of congestive heart failure in patients at risk for myocardial infarction or stroke. In patients with hyperlipidemia, it is used as an adjunct to dietary therapy to decrease total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels, and to increase HDL cholesterol levels. It is particularly effective for patients with familial hypercholesterolemia and those with dyslipidemia. It is also used in children aged 10 to 17 years with heterozygous familial hypercholesterolemia to improve lipid levels.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma atorvastatin concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate to meet the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms; therefore, if severe muscle pain, weakness, or cramps occur, discontinue use immediately and consult a physician. Treatment should be stopped if muscle enzyme levels are significantly elevated or if muscle disease is suspected. Patients with active liver disease or severely impaired liver function should not take this medication. Women who are pregnant, may become pregnant, or are breastfeeding, as well as children under 10 years of age, should not use this medication. Patients with a history of alcohol abuse or liver disease must exercise caution when taking this medication and should have regular liver function tests. Since this medication may affect liver function, any symptoms such as nausea, vomiting, or fatigue should be reported to a doctor immediately. Regular monitoring of liver function and muscle status is important while on this medication. Caution is required when taking this drug with other medications, especially certain antibiotics, antifungals, HIV treatments, and other lipid-lowering agents. Taking grapefruit juice with this medication may increase its blood concentration, so grapefruit juice should be avoided. This medication contains lactose, so patients with lactose intolerance should not take it. Adequate contraceptive methods should be used while on this medication, and use should be discontinued immediately if pregnancy is confirmed. Elderly patients and those with impaired renal function are at greater risk for muscle disease and should be monitored closely during use. There is no specific antidote for overdose; thus, treatment should be symptomatic, along with monitoring of liver function and muscle enzyme levels. This medication should be stored out of reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to keep it at a room temperature that is not too hot or too cold.
White oval film-coated tablets
Domestic: 30 tablets/bottle, 100 tablets/bottle Export: 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.